Loading…
Based on limited metadata, RadLogics, Inc. received an FDA Warning Letter dated April 5, 2018, regarding a product classified as "Other," indicating it does not fit standard device or drug categories. Without access to the full letter text or specific subject line details, the exact nature of the violations cannot be determined with certainty. The issuing office information is unavailable, which limits clarity on the specific regulatory division involved. To understand the precise regulatory concerns and required corrective actions, the complete Warning Letter document would be necessary.